Clincosm LogoSign in Get a demo

refractory malignant neoplasm

Showing 1 - 10 of 10
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Care Giver, Recurrent Malignant Tumor, Refractory Malignant Tumor Trial in Nashville (Internet-Based Intervention, Best

Completed
  • Care Giver
  • +2 more
  • Internet-Based Intervention
  • +3 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Jan 28, 2023

Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Everolimus, Laboratory

Recruiting
  • Advanced Malignant Neoplasm
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 9, 2022

Financial Distress in Advanced Cancer Patients

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +4 more
  • Medical Chart Review
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +38 more
  • Bevacizumab
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Skin Squamous Cell Carcinoma, Appendix Adenocarcinoma, Rare Lesion Trial in Houston (Atezolizumab, Cobimetinib)

Active, not recruiting
  • Skin Squamous Cell Carcinoma
  • +11 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 3, 2022

Advanced Malignant Tumor, Fatigue, Metastatic Malignant Tumor Trial in Houston (drug, behavioral, other)

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 3, 2022

Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 21, 2022

Human Papillomavirus-16 Positive, Human Papillomavirus-18 Positive, Metastatic Malignant Tumor Trial in Houston (DNA

Active, not recruiting
  • Human Papillomavirus-16 Positive
  • +20 more
  • DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457
  • Durvalumab
  • Houston, Texas
    M D Anderson Cancer Center
Feb 11, 2022

Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Anakinra, Denosumab,

Completed
  • Advanced Malignant Neoplasm
  • +3 more
  • Anakinra
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 24, 2021

Advanced Malignant Tumor, BRAF Gene Mutation, Metastatic Malignant Tumor Trial in Houston (Crizotinib, Laboratory Biomarker

Completed
  • Advanced Malignant Neoplasm
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2021